System solution for syringes, vials and cartridges - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

 

Optima Pharma has, in the form of the INOVA SV, a well proven machine that had been re-engineered in recent years into a highly flexible modular system.

The INOVA SV allows the processing of nested ready to use syringes, of nested vials and cartridges in one unit. Customers make a quick change within 30 minutes. The contact points of the system to the containers are reduced to an absolute minimum to allow for gentler processing. In addition, there is no glass to glass contact of any kind during the processing. A further factor concerns the filling systems. A number of variations are possible, all of which can be set up very quickly as part of the format change work: Rotary piston pumps, peristaltic pumps, mass flow metering and time-pressure systems offer advantages relative to the various types of pharmaceuticals. Additional modules and functions can be integrated, including filling under vacuum, pre- and post-flushing with gas, and up to 100% in-process control. Upstream, the pre-sterilized containers are manually to fully automatically unpacked and fed to the process. The post-processing section features such modules as backstop locks and safety devices, optical and sensor controls, labelers and track & trace systems. RAB systems and isolators can be deployed. A maximum output of 18,000 containers/hour is achieved via ten filling points, with a dosing range of 0.1 to 50 ml.

OPTIMA pharma GmbH
www.optima-pharma.com
E-mail: info@optima-pharma.com

 

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
FindPharma Custom Search

Click here